The secretome profile of the LUAD cell lines had a broad scope of biological functions (Figure 3C) which may be due to additional genetic changes specific to each NSCLC cell line, beyond EGFR and p53, such as p16 that can affect the secretome profile (90, 91). Here, CDKN2A is linked to non-small cell lung carcinoma.